Alcon Inc. (SIX/NYSE: ALC), the global leader in eye care
dedicated to helping people see brilliantly, today announced the
results of its 2021 Annual General Meeting.
Given the global COVID-19 outbreak, Alcon previously directed
shareholders to send their voting instructions to the independent
representative, Hartmann Dreyer Attorneys-at-Law.
Shareholders showed a high level of interest and engagement in
the resolutions proposed, with a total of 347,227,434 Alcon Inc.
shares, corresponding to 70.87% of the shares entitled to vote,
represented.
Shareholders re-elected Mike Ball as Chair of the Board of
Directors and all members of the Board who stood for re-election,
namely Lynn Bleil, Arthur Cummings, David Endicott, Thomas
Glanzmann, D. Keith Grossman, Scott Maw, Karen May, Ines P�schel
and Dieter Spälti, for a term of one year. Shareholders also
re-elected Karen May, Thomas Glanzmann and Ines P�schel to the
Compensation Committee. Discharge was granted to the members of the
Board of Directors and the members of the Executive Committee for
the 2020 financial year.
In two binding votes, shareholders showed strong support
approving the maximum aggregate amount of compensation of the Board
of Directors for the next term of office ending at the 2022 Annual
General Meeting and the Executive Committee for 2022. In a
non-binding consultative vote, shareholders did not approve the
2020 Compensation Report. Minutes of the meeting are available on
Alcon’s Investor Relations website.
“On behalf of the entire Board of Directors, I want to thank our
shareholders for their strong participation in our Annual General
Meeting and for the trust you place in Alcon to continue leading on
our promise of helping people See Brilliantly,” said Mike Ball. “We
appreciate that our shareholders have shared their voice, and we
take their input very seriously. We have a robust investor outreach
program and are committed to bringing their ideas and insights into
these discussions later this year. The Board is pleased with the
tremendous progress the Company has achieved, despite the
challenges of the global pandemic, by successfully executing new
product launches, gaining market share on key products, remaining
on track with strategic initiatives and maintaining full employment
of its associates. As the markets recover, Alcon is well positioned
with its innovative product portfolio to drive long-term
shareholder value and sustainable growth.”
Alcon shareholders approved the operating and financial review
of Alcon Inc., the annual financial statements of Alcon Inc. and
the consolidated financial statements for 2020.
Shareholders approved the dividend declaration of CHF 0.10 per
share, the Company’s first dividend. After the appropriation of the
proposed dividend, an amount of CHF 160,000 will be allocated to
the general reserve, and the remaining amount of available earnings
will be carried forward.
Pricewaterhouse Coopers SA, Geneva, was re-elected as statutory
auditors for the 2021 financial year. Hartmann Dreyer
Attorneys-at-Law was re-elected as the independent representative
for a term of one year, extending until the 2022 Annual General
Meeting.
Alcon will announce its first-quarter 2021 earnings on May 4
after the close of the U.S. markets, with an investor call
scheduled for May 5.
Cautionary Note Regarding
Forward-Looking Statements This press release contains
“forward-looking statements” within the meaning of the safe harbor
provisions of the United States Private Securities Litigation
Reform Act of 1995. Forward-looking statements can be identified by
words such as: “anticipate,” “intend,” “commitment,” “look
forward,” “maintain,” “plan,” “goal,” “seek,” “target,” “assume,”
“believe,” “project,” “estimate,” “expect,” “strategy,” “future,”
“likely,” “may,” “should,” “will” and similar references to future
periods. An example of a forward-looking statement includes, among
others, statements Alcon makes regarding the payment of a
dividend.
Forward-looking statements are neither historical facts nor
assurances of future performance. Instead, they are based only on
our current beliefs, expectations and assumptions regarding the
future of our business, future plans and strategies, and other
future conditions. Because forward-looking statements relate to the
future, they are subject to inherent uncertainties and risks that
are difficult to predict. Some of these factors are discussed in
our filings with the United States Securities and Exchange
Commission, including our Form 20-F. Should one or more of these
uncertainties or risks materialize, or should underlying
assumptions prove incorrect, actual results may vary materially
from those anticipated. Therefore, you should not rely on any of
these forward-looking statements.
Forward-looking statements in this press release speak only as
of the date they are made, and we assume no obligation to update
forward-looking statements as a result of new information, future
events or otherwise.
ABOUT ALCON Alcon helps
people see brilliantly. As the global leader in eye care with a
heritage spanning more than seven decades, we offer the broadest
portfolio of products to enhance sight and improve people’s lives.
Our Surgical and Vision Care products touch the lives of more than
260 million people in over 140 countries each year living with
conditions like cataracts, glaucoma, retinal diseases and
refractive errors. Our more than 23,000 associates are enhancing
the quality of life through innovative products, partnerships with
eye care professionals and programs that advance access to quality
eye care. Learn more at www.alcon.com.
Connect with us on Facebook LinkedIn
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210428005801/en/
Investor Relations Christina
Cheng + 41 589 112 110 (Geneva) + 1 817 615 2789 (Fort Worth)
investor.relations@alcon.com
Media Relations Wes Warnock
+ 41 589 112 111 (Geneva) + 1 817 615 2501 (Fort Worth)
globalmedia.relations@alcon.com
Alcon (NYSE:ALC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Alcon (NYSE:ALC)
Historical Stock Chart
From Jul 2023 to Jul 2024